ONCOMED PHARMACEUTICALS INC's ticker is OMED and the CUSIP is 68234X102. A total of 87 filers reported holding ONCOMED PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $2,934,000 | -29.9% | 380,570 | +3.9% | 0.00% | -100.0% |
| Q3 2016 | $4,188,000 | +20.4% | 366,418 | +29.7% | 0.00% | 0.0% |
| Q2 2016 | $3,477,000 | +29.7% | 282,483 | +6.5% | 0.00% | – |
| Q1 2016 | $2,681,000 | -54.4% | 265,174 | +1.7% | 0.00% | -100.0% |
| Q4 2015 | $5,879,000 | +58.0% | 260,839 | +16.3% | 0.00% | 0.0% |
| Q3 2015 | $3,721,000 | +20.1% | 224,284 | +62.8% | 0.00% | – |
| Q2 2015 | $3,099,000 | -6.3% | 137,747 | +7.4% | 0.00% | -100.0% |
| Q1 2015 | $3,306,000 | +21.6% | 128,220 | +2.6% | 0.00% | – |
| Q4 2014 | $2,719,000 | +12.6% | 124,963 | -2.0% | 0.00% | – |
| Q3 2014 | $2,414,000 | -40.7% | 127,515 | -27.0% | 0.00% | -100.0% |
| Q2 2014 | $4,070,000 | +58.9% | 174,683 | +129.4% | 0.00% | – |
| Q1 2014 | $2,562,000 | -1.0% | 76,150 | -13.2% | 0.00% | – |
| Q4 2013 | $2,589,000 | +3.8% | 87,717 | -46.2% | 0.00% | – |
| Q3 2013 | $2,495,000 | – | 162,954 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADAMS STREET PARTNERS LLC | 1,839,730 | $16,944,000 | 4.17% |
| BVF INC/IL | 1,760,489 | $16,214,000 | 2.76% |
| Iguana Healthcare Management, LLC | 490,000 | $4,513,000 | 2.23% |
| Broadfin Capital, LLC | 300,000 | $2,763,000 | 0.34% |
| TURNER INVESTMENTS LLC | 38,083 | $351,000 | 0.23% |
| Birchview Capital, LP | 34,689 | $319,000 | 0.18% |
| Piermont Capital Management Inc. | 52,195 | $481,000 | 0.12% |
| Cannell & Co. | 331,296 | $3,051,000 | 0.11% |
| NJ State Employees Deferred Compensation Plan | 48,000 | $442,000 | 0.08% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 324,350 | $2,987,000 | 0.07% |